Company: ARTL
Filing Date: 2025-12-11
Form Type: DEF 14A
Source: 0001640334-25-002308
Chunk: 12

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-12-11
Form: DEF 14A
Chunk 12
---
,666 shares of Common Stock issuable pursuant to options held directly by Mr. Spring exercisable within 60 days of December 10, 2025.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| (9) | Includes (i) 160,736 shares of Common Stock and (ii) 71,107 shares of Common Stock underlying options held by all directors and officers as a group that are exercisable as of December 10, 2025 or that will become exercisable within 60 days after such date.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |

| 6 |

<div align='center'>CORPORATE GOVERNANCE</div>

Composition of the Board

Our Board currently consists of seven directors, six of whom are independent under the listing standards of The Nasdaq Stock Market LLC, or Nasdaq.

The following table sets forth the names, ages as of December 10, 2025, and certain other information for each of our directors and director nominees:

| Name                      
 Gregory D. Gorgas         
 Connie Matsui             |     | Age | 62 
 71 |     | Position Held with the Company                             
 President, Chief Executive Officer, Secretary and Director 
 Director, Chairperson of the Board                         |     | Date first appointed 
 April 3, 2017        
 May 2, 2017          |
|:--------------------------|:----|:----|---:|:----|:-----------------------------------------------------------|:----|:---------------------|
| Steven Kelly              |     |     | 60 |     | Director                                                   |     | May 2, 2017          |
| Douglas Blayney, M.D.     |     |     | 75 |     | Director                                                   |     | July 31, 2017        |
| R. Martin Emanuele, Ph.D. |     |     | 70 |     | Director                                                   |     | September 20, 2017   |
| Greg Reyes, M.D., Ph D.   |     |     | 71 |     | Director                                                   |     | November 30, 2020    |
| Tamara A. Favorito        |     |     | 67 |     | Director                                                   |     | March 3, 2021        |

Director Nominees

Douglas Blayney, M.D.was elected to our Board in July 2017. Dr. Blayney is a Professor of